SCOPUS 정보 검색 플랫폼

Volumn 20, Issue 118, 2011, Pages

Fingolimod

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; CLADRIBINE; CORTICOSTEROID; FINGOLIMOD; PLACEBO; BETA INTERFERON; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; PROPANEDIOL DERIVATIVE; SPHINGOSINE;

CANCER RISK; CORTICOSTEROID THERAPY; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MECHANISM; DRUG OVERDOSE; DRUG SAFETY; DRUG SUBSTITUTION; EUROPEAN UNION; EYE DISEASE; HEART DISEASE; HERPES SIMPLEX; HUMAN; LIVER DISEASE; LYMPHOCYTE COUNT; MULTIPLE SCLEROSIS; SHORT SURVEY; TREATMENT INDICATION; TREATMENT OUTCOME; ARTICLE; CLINICAL TRIAL (TOPIC);

CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-BETA; MULTIPLE SCLEROSIS; PROPYLENE GLYCOLS; SPHINGOSINE;

EID: 79961114422 PISSN: 11677422 EISSN: None Source Type: Journal
DOI: None Document Type: Short Survey

Times cited : (1)

References (8)

1
- 79959791215
- Novartis 5 May
- Novartis "Fingolimod (NDA 22- 527) Briefing document" 5 May 2010: 112 pages.
- (2010) Fingolimod (NDA 22- 527) Briefing Document , pp. 112

2
- 76149140914
- Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis
- Cohen JA et al. "Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis" N Engl J Med 2010; 362 (5): 402-415.
- (2010) N Engl J Med , vol.362 , Issue.5 , pp. 402-415
- Cohen, J.A.¹

3
- 76149093586
- A placebo controlled trial of oral fingolimod in relapsing multiple sclerosis
- Kappos L et al. "A placebo controlled trial of oral fingolimod in relapsing multiple sclerosis" N Engl J Med 2010; 362 (5): 387-401.
- (2010) N Engl J Med , vol.362 , Issue.5 , pp. 387-401
- Kappos, L.¹

4
- 77950610346
- Hartung HP and Aktas O "Oral therapies for multiple sclerosis: are we there yet?" www.thelancet.com/neurology 2010; 9: 454-457.
- (2010) Oral Therapies for Multiple Sclerosis: Are We There Yet? , vol.9 , pp. 454-457
- Hartung, H.P.¹ Aktas, O.²

5
- 79959793942
- U.S. Food and Drug Administration - Center for Drug Evaluation and Research 18 May
- U.S. Food and Drug Administration - Center for Drug Evaluation and Research "Fingolimod (NDA 22-527) Background package. Memorandum" 18 May 2010: 29 pages.
- (2010) Fingolimod (NDA 22-527) Background Package. Memorandum , pp. 29

6
- 79959772126
- U.S. Food and Drug Administration - Center for Drug Evaluation and Research 12 May
- U.S. Food and Drug Administration - Center for Drug Evaluation and Research "Fingolimod (NDA 22-527) Clinical review safety" 12 May 2010: 233 pages.
- (2010) Fingolimod (NDA 22-527) Clinical Review Safety , pp. 233

7
- 79959807924
- U.S. Food and Drug Administration - Center for Drug Evaluation and Research 1 July
- U.S. Food and Drug Administration - Center for Drug Evaluation and Research "Application number 22.527 - Statistical review(s)" 1 July 2010: 35 + 30 pages.
- (2010) Application Number 22.527 - Statistical Review(s)

8
- 79959796952
- Haute autorité de santé. Commission de la transparence July
- Haute autorité de santé. Commission de la transparence "Sclérose en plaques. Interférons β et acétate de glatiramère. Réévaluation" July 2010: 34 pages.
- (2010) Sclérose en Plaques. Interférons β et Acétate de Glatiramère. Réévaluation , pp. 34

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.